Akèy › Enfeksyon Viral › Maryland
Etid klinik pou Enfeksyon Viral nan Maryland
14 etid pou Enfeksyon Viral ap chèche patisipan nan sit nan Maryland.
Vil nan Maryland
Tèks ofisyèl etid la (Anglè)
Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
- Research Site, Annapolis
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT05624450Specimen Collections From Participants With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and Cancer
- National Institutes of Health Clinical Center, Bethesda
Ap rekriteEtid obsèvasyon
Laj 18 a 120 · Tout sèks · Mizajou Sep 28, 2026 · NCT00006518The Natural History of Severe Viral Infections and Characterization of Immune Defects in Patients Without Known Immunocompromise
- National Institutes of Health Clinical Center, Bethesda
Ap rekriteEtid obsèvasyon
Laj 2 a 100 · Tout sèks · Mizajou Sep 28, 2026 · NCT01011712A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
- Centennial Medical Group, Columbia
- Jadestone Clinical Research, Silver Spring
Ap rekriteFaz 3
Laj 12 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT06679140A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
- Johns Hopkins Hospital, Baltimore
- Jadestone Clinical Research, Silver Spring
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT07013474Phase 1 Challenge Study Using rDEN2delta30-7169 to Evaluate Host-Pathogen Interactions in Primary, Homotypic, and Heterotypic Dengue Virus Infection
- National Institutes of Health Clinical Center, Bethesda
Ap rekriteFaz 1Volontè an sante akeyi
Laj 18 a 50 · Tout sèks · Mizajou Sep 25, 2026 · NCT07706686Study of AHB-137 in Chronic Hepatitis B (CHB) Participants in North America and Europe Regions
- University of Maryland, Baltimore
Ap rekriteFaz 2
Laj 18 a 65 · Tout sèks · Mizajou Sep 24, 2026 · NCT07654283Evaluating the Dose, Safety, Tolerability, and Immunogenicity of Mosaic Hexavalent Influenza Vaccine VRCFLUMOS0116-00-VP (FluMos-v2) With and Without ALFQ Adjuvant in Healthy Adults
- National Institutes of Health Clinical Center, Bethesda
Ap rekriteFaz 1Volontè an sante akeyi
Laj 18 a 50 · Tout sèks · Mizajou Sep 15, 2026 · NCT06863142Viral Infections in Healthy and Immunocompromised Hosts
- National Institutes of Health Clinical Center, Bethesda
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
6 Months – 120 Years · Tout sèks · Mizajou Sep 14, 2026 · NCT01306084Acute Infection in Mitochondrial Disease: Metabolism, Infection and Immunity
- National Institutes of Health Clinical Center, Bethesda
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
2 Months – 115 Years · Tout sèks · Mizajou Sep 10, 2026 · NCT04419870Genetic Studies of Chronic Active Epstein-Barr Disease
- National Institutes of Health Clinical Center, Bethesda
Ap rekriteEtid obsèvasyon
Laj 1 a 120 · Tout sèks · Mizajou Jul 28, 2026 · NCT00032513Treatment of Refractory BK Infections With Related Donor BK Specific Cytotoxic T-cells (CTLs)
- Johns Hopkins, Baltimore
Ap rekriteFaz 1/2
1 Month – 79 Years · Tout sèks · Mizajou Apr 15, 2026 · NCT04197596Adoptive T Lymphocyte Administration for Chronic Norovirus Treatment in Immunocompromised Hosts
- Johns Hopkins University, Baltimore
- National Institutes of Health (NIH), Bethesda
Ap rekriteFaz 1
3 Months – 80 Years · Tout sèks · Mizajou Jan 26, 2026 · NCT04691622Medical Herbs Inhibit Inflammation Directing T Cells to Kill the COVID-19 Virus (COVID)
- All Natural Medicine Clinic, LLC, Rockville
Ap rekriteFaz 1/2
Tout laj · Tout sèks · Mizajou Feb 19, 2025 · NCT04790240Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.